Literature DB >> 19396866

Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.

Brian J Henson1, Samsiddhi Bhattacharjee, Dawn M O'Dee, Eleanor Feingold, Susanne M Gollin.   

Abstract

Altered microRNA (miRNA) expression profiles have been observed in numerous malignancies, including oral squamous cell carcinoma (OSCC). However, their role in disease is not entirely clear. Several genetic aberrations are characteristic of OSCC, with amplification of chromosomal band 11q13 and loss of distal 11q being among the most prevalent. It is not known if the expression levels of miRNAs in these regions are altered or whether they play a role in disease. We hypothesize that the expression of miRNAs mapping to 11q are altered in OSCC because of loss or amplification of chromosomal material, and that this contributes to the development and progression of OSCC. We found that miR-125b and miR-100 are down-regulated in OSCC tumor and cell lines, and that transfecting cells with exogenous miR-125b and miR-100 significantly reduced cell proliferation and modified the expression of target and nontarget genes, including some that are overexpressed in radioresistant OSCC cells. In conclusion, the down-regulation of miR-125b and miR-100 in OSCC appears to play an important role in the development and/or progression of disease and may contribute to the loss of sensitivity to ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396866      PMCID: PMC2726991          DOI: 10.1002/gcc.20666

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  85 in total

1.  KLF13 influences multiple stages of both B and T cell development.

Authors:  Susan V Outram; Adele R Gordon; Ariadne L Hager-Theodorides; James Metcalfe; Tessa Crompton; Paul Kemp
Journal:  Cell Cycle       Date:  2008-05-05       Impact factor: 4.534

2.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.

Authors:  Paul J Hensbergen; Pepijn G J T B Wijnands; Marco W J Schreurs; Rik J Scheper; Rein Willemze; Cornelis P Tensen
Journal:  J Immunother       Date:  2005 Jul-Aug       Impact factor: 4.456

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.

Authors:  Thian-Sze Wong; Xiao-Bing Liu; Birgitta Yee-Hang Wong; Raymond Wai-Man Ng; Anthony Po-Wing Yuen; William Ignace Wei
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

6.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

7.  Widespread deregulation of microRNA expression in human prostate cancer.

Authors:  M Ozen; C J Creighton; M Ozdemir; M Ittmann
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

Review 8.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

9.  MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Heike Varnholt; Uta Drebber; Falko Schulze; Inga Wedemeyer; Peter Schirmacher; Hans-Peter Dienes; Margarete Odenthal
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

Review 10.  Understanding the immunoangiostatic CXC chemokine network.

Authors:  Maria Luisa Balestrieri; Antonio Balestrieri; Francesco Paolo Mancini; Claudio Napoli
Journal:  Cardiovasc Res       Date:  2008-02-05       Impact factor: 10.787

View more
  103 in total

1.  Overexpression of KLF13 and FGFR3 in oral cancer cells.

Authors:  B J Henson; S M Gollin
Journal:  Cytogenet Genome Res       Date:  2010-06-02       Impact factor: 1.636

2.  Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.

Authors:  Andrew Jakymiw; Rushi S Patel; Natasha Deming; Indraneel Bhattacharyya; Priya Shah; Richard J Lamont; Carol M Stewart; Donald M Cohen; Edward K L Chan
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

3.  MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Authors:  Menno R Vriens; Julie Weng; Insoo Suh; Nhung Huynh; Marlon A Guerrero; Wen T Shen; Quan-Yang Duh; Orlo H Clark; Electron Kebebew
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

4.  MicroRNA-125b potentiates macrophage activation.

Authors:  Aadel A Chaudhuri; Alex Yick-Lun So; Nikita Sinha; William S J Gibson; Konstantin D Taganov; Ryan M O'Connell; David Baltimore
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

5.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

6.  miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.

Authors:  S Bhattacharjya; S Nath; J Ghose; G P Maiti; N Biswas; S Bandyopadhyay; C K Panda; N P Bhattacharyya; S Roychoudhury
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

7.  Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.

Authors:  Felice H Tsang; Victor Au; Wen-Jing Lu; Felix H Shek; Angela M Liu; John M Luk; Sheung-Tat Fan; Ronnie T P Poon; Nikki P Lee
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

8.  miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.

Authors:  G Yang; Y Gong; Q Wang; L Wang; X Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

9.  MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells.

Authors:  Brian S Letzen; Cyndi Liu; Nitish V Thakor; John D Gearhart; Angelo H All; Candace L Kerr
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

10.  MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation.

Authors:  Francisco J Ortega; José M Moreno-Navarrete; Gerard Pardo; Monica Sabater; Manuela Hummel; Anna Ferrer; Jose I Rodriguez-Hermosa; Bartomeu Ruiz; Wifredo Ricart; Belen Peral; José M Fernández-Real
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.